Applied Therapeutics APLT 深 滬
已收盤 10-03 16:00:00 美东时间
1.00
+0.066
+7.04%
華盛通- 最 高1.05
- 今 開0.942
- 成交量 939.06万股
- 最 低 0.8761
- 昨 收 0.9342
- 總市值 1.44亿
- 52周最高 10.6237
- 市盈率 靜 --
- 換手率 6.52%
- 52周最低 0.295
- 委 比 33.33%
- 總股本 1.44亿
- 歷史最高 57.39
- 量 比 0.23
- 振 幅 18.61%
- 歷史最低 0.295
- 每 手 1
- 風險率 3.12%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股牛股 | TSHA飙升超53%，试验性治疗获FDA突破性疗法认定；嘉楠科技大涨近27%
TSHA飙升超53%，试验性治疗获FDA突破性疗法认定；嘉楠科技大涨近27%，比特币重返12万美元叠加公司获得大规模矿机订单；ONDS涨26%，获国防无人机订单>>
10-03 19:10
Applied Therapeutics Meets With FDA On Potential Drug Filing For Rare Nerve Disease CMT-SORD
Applied Therapeutics, Inc. (NASDAQ: APLT) (the Company), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare diseases, today announced that the Company completed a meeting with the U.S.
09-29 19:34
Applied Therapeutics Provides Update Following Meeting with FDA
Applied Therapeutics Inc. (APLT) held a meeting with the FDA to discuss the potential NDA submission for govorestat to treat Charcot-Marie-Tooth Sorbitol Dehydrogenase (SORD) Deficiency (CMT-SORD). The company is awaiting FDA meeting minutes to determine next steps, with no final submission strategy or accelerated approval pathway decided yet. CMT-SORD is a rare, progressive neuropathy affecting approximately 3,300 patients in the U.S. and 4,000 ...
09-29 11:00
纳斯达克生物科技指数收涨将近1.5%
成分股Applied Therapeutics收涨119.56%，Crinetics Pharma涨27.92%，Annexon涨20.79%表现第三。Kyv...
09-27 04:30
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The market value of their outstanding shares is at $3.6 million.
09-27 01:05
Applied Therapeutics Announces New Equity Offering Agreement
The latest update is out from Applied Therapeutics ( ($APLT) ). On August 29, 2...
08-30 04:29
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers OSR Holdings (NASDAQ:OSRH) shares rose 34.6% to $0.7 during Friday's a...
08-23 05:07
Applied Therapeutics GAAP EPS of -$0.15 beats by $0.01
Applied Therapeutics press release (NASDAQ:APLT): Q2 GAAP EPS of -$0.15 beats by $0.01. Cash and cash equivalents totaled $30.4 million as of June 30, 2025, compared with $79.4 million at December 31,...
08-14 15:38
Applied Therapeutics Advances Pipeline Amid Financial Challenges
Applied Therapeutics ( ($APLT) ) has released its Q2 earnings. Here is a breakd...
08-14 12:30
Applied Therapeutics Q2 EPS $(0.15) Beats $(0.16) Estimate
Applied Therapeutics (NASDAQ:APLT) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.16) by 5.06 percent. This is a 15.38 percent decrease over losses of $(0.13) per share
08-14 05:12
